Institute for Molecular Medicine (FIMM) - Helsingin yliopisto, Finland

The Institute for Molecular Medicine Finland FIMM is an international research institute focusing on building a bridge from discovery to medical applications. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, together with the Centre for Molecular Medicine Norway (NCMM, University of Oslo) and the Laboratory for Molecular Infection Medicine Sweden (MIMS, Umeå University). At the national level FIMM is a joint research institute of the University of Helsinki, the Hospital District of Helsinki and Uusimaa (HUS), the National Institute for Health and Welfare (THL) and the VTT Technical Research Centre of Finland.

The mission of FIMM is to advance new fundamental understanding of the molecular, cellular and etiological basis of human diseases. This understanding will lead to improved means of diagnostics and the treatment and prevention of common health problems. Finnish clinical and genetic-epidemiological materials will be available for these studies.

The aim of FIMM is to merge strategic resources and research in the field of molecular medicine, genetics and epidemiology in Finland, and to develop into a high-profile international research institute in molecular medicine.

FIMM is hosted by the University of Helsinki which is also the legal entity for FIMM. The University of Helsinki was established in 1640 and now constitutes the largest and most versatile university in Finland. The University has ca. 38.400 students and 7.900 employees; activities are located on four campuses. High-level research is carried out at the departments of the faculties and departmentally affiliated research stations, as well as at independent research institutes (such as FIMM). The university places special emphasis on the quality of education and research, and is a member of the League of the European Research Universities (LERU).

To the website of Helsingin yliopisto (FIMM)